Stop TB Partnership

Selection Criteria, Committee, and Ceremony

Selection Criteria

  • The extent of creativity or innovation used to overcome adversity;
  • The extent to which the results advanced progress or work in TB; and
  • The extent to which the prize money can contribute to the fight against TB.

Selection Committee is composed of:

Mr Timur Abdullaev
Stop TB Partnership Board Member

Dr Kenneth Castro
Clinical Assistant Professor, Emory University School of Public Health
United States of America

Dr Paula Fujiwara
Scientific Director, International Union Against Tuberculosis and Lung Disease

Mr. Woo Young Soo
Executive Director, Kochon Foundation
Republic of Korea

Dr Mel Spigelman
President and CEO, Global Alliance for TB Drug Development
Co-Chair, Working Group on New TB Drugs
United States of America

Award Announcement and Ceremony

Details of the 2021 Kochon Prize will be announced at a later date.